For information about COVID-19, including symptoms and prevention, please read our COVID-19 patient guide. Please also consider supporting Weill Cornell Medicine’s efforts against the pandemic.


October 20, 2020 - 4:30pm
Fall/Winter 2020-2021 Department of Pharmacology Postdoctoral Associate Seminar Series Grady Nelson, Ph.D. Lab of Dr. Yueming Li Department of Chemistry Biology Memorial Sloan Kettering Cancer Center For additional informarmation please contact: Lissett Checo, email: Phone: 212-746-6250
October 20, 2020 - 5:00pm
Fall/Winter 2020/2021 Department of Pharmacology Postdoctoral Associate Seminar Series Sara Zaccara, Ph.D. Lab of Dr. Samie Jaffrey Department of Pharmacology Weill Cornell Medicine For additional information please contact: Lissett Checo, email Phone: 212-746-6250
October 21, 2020 - 2:00pm
"Using iPSCs and ‘omics to identify mechanisms of neurodegenerative diseases"
October 21, 2020 - 5:00pm
Dean’s Distinguished Lecture Series October 21, 2020 4-5pm Zoom lecture Register here Introduction: Shuibing Chen, PhD Kilts Family Associate Professor of Surgery Lecture: “The Chemistry of Life: From an Expanded Genetic Code to Controlling Cell Fate” Peter G. Schultz, PhD President and CEO, The Scripps Research Institute Scripps Family Chair Professor, Department of Chemistry Questions & Answers
October 22, 2020 - 1:00pm
Biochemistry and Cell & Developmental Biology Lecture Series presents: David Hodson, BVSc, Ph.D.,FRCVS Professor of Cellular Metabolism Institute of Systems Metabolism and Research University of Birmingham U.K.
October 22, 2020 - 5:30pm
This symposium is designed for faculty, trainees, and students interested in advancing their research from the lab to the clinic. Learn about ways to partner with industry and the resources available at BioPharma Alliances and Research Collaborations, the Tri-Institutional Therapeutics Discovery Institute, Bridge Medicines, and the Center for Technology Licensing. Keynote Address by: John Maraganore, PhD Chief Executive Officer Alnylam Pharmaceuticals Alnylam has led the translation of RNAi (RNA interference) from Nobel Prize-winning discovery into an innovative, entirely new class of medicines. Featured Speakers: John P. Leonard, MD Senior Associate Dean for Innovation and Initiatives Richard T. Silver Distinguished Professor of Hematology and Medical Oncology Weill Cornell Medicine "Updates on Weill Cornell Medicine's Innovation Ecosystem" and Li Gan, PhD Director, Helen and Robert Appel Alzheimer’s Disease Research Institute Burton P. and Judith B. Resnick Distinguished Professor in Neurodegenerative Diseases, Feil Family Brain and Mind Research Institute Weill Cornell Medicine "Developing New Therapeutics for Neurodegenerative Disease"
October 27, 2020 - 5:00pm
"OligoTEAs: A Platform for the Design and Quantification of Multifunctional Antibody Drug Carriers" Christopher Alabi, Ph.D. Assistant Professor, Nancy and Peter Meinig Family Investigator in Life Sciences Cornell University, Ithaca, NY Host: Dr. Daniel Heller
October 28, 2020 - 5:00pm
On Wednesday, October 28 at 4:00 P.M., Dr. Elaine Fuchs will interview Dr. Karen Akinsanya about her distinguished scientific career, her innovative and exciting work at Schrödinger, and her advice to researchers about the field of biotechnology. Webinar attendees will then be able to partake in a live Q&A with Drs. Akinsanya and Fuchs. To register:
November 5, 2020 - 6:00pm
Target Audience – Patients who would benefit from understanding how best to navigate the complex health system and be made aware of the supportive services available to help them coordinate care. Providers to understand the challenges that patients face. From disciplines of rare disease such as melanoma, brain cancers, and sarcoma among others. Goals – In alignment with the Dan McMenamin Endowment (DME) mission, the event strives to foster cooperation among patients, physicians, and researchers by educating patients on the complexities of collaborative care and offering resources to guide the patient in making informed decisions about their care. The target audience for the event is patients and caregivers of those diagnosed with or have the potential for diagnosis of rare cancers. Physicians and researchers in the rare disease space will also be encouraged to attend to hear directly from patients/caregivers and improve their knowledge of patient-centric care. Event Program: Opening Remarks & Introductions Antonio P. DeRosa (WCM) will provide an overview of the event and opening remarks “Dancing with Uncertainty: Important Decisions & Limited Information” Dr. Guy Maytal (WCM) speaking on psychosocial aspects of genetic testing “Genetics, Genomics, Family History and Cancer” Dr. Nicolas Robine (New York Genome Center) speaking on genomic testing and family history of disease “It may not be rare, but it is no less significant” Ms. Nila Charles (Patient Advisor – NYP/WCM Cancer Center PFAC) speaking on the patient perspective with genetic testing Panel Discussion and Q&A Moderated by Dr. Andrea Betesh (WCM) and Michelle Primiano (WCM) from the Clinical Cancer Genetics team
November 12, 2020 - 1:00pm
Biochemistry and Cell & Developmental Biology Lecture Series presents: Rejji Kuruvilla, Ph.D. Professor, Dept. of Biology Johns Hopkins University

Weill Cornell Medicine Graduate School of Medical Sciences 1300 York Ave. Box 65 New York, NY 10065 Phone: (212) 746-6565 Fax: (212) 746-5981